Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01524107
Other study ID # CSURGENT-ELECT-HMO-CTIL
Secondary ID
Status Recruiting
Phase N/A
First received January 30, 2012
Last updated December 18, 2016
Start date January 2012

Study information

Verified date December 2016
Source Hadassah Medical Organization
Contact Drorith Hochner-Celnikier, MD
Phone 00 972 2 5844400
Email hochner@hadassah.org.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The medical literature does not provide sufficient information or recommendation regarding specific antibiotic coverage for urgent Caesarian sections. The goal of this study is to compare maternal and neonatal morbidity of women who have undergone urgent Caesarian Sections for Prolapsed Cord to those who have undergone Elective Caesarian Sections in order to develop a standard treatment protocol. The Medical Record review will include many parameters including complications, type of antibiotic usage etc.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- women undergoing urgent Caesarian Section for Prolapsed Cord.

- women undergoing Elective Caesarian Section.

Exclusion Criteria:

- preterm birth

- multiple gestation

Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms

  • Prolapse
  • Urgent Caesarian Section Secondary to Cord Prolapse

Locations

Country Name City State
Israel Hadassah Medical Organization Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel,